Profile data is unavailable for this security.
About the company
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
- Revenue in USD (TTM)4.38m
- Net income in USD-7.94m
- Incorporated2001
- Employees26.00
- LocationNeuroMetrix Inc1000 Winter StreetWALTHAM 02451United StatesUSA
- Phone+1 (781) 890-9989
- Fax+1 (302) 636-5454
- Websitehttps://www.neurometrix.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Telesis Bio Inc | 16.28m | -50.12m | 5.48m | 137.00 | -- | -- | -- | 0.3365 | -29.66 | -30.68 | 9.61 | 5.61 | 0.1947 | 3.15 | 3.40 | 118,832.10 | -57.15 | -- | -64.21 | -- | 49.47 | -- | -293.54 | -- | 1.72 | -52.96 | 0.356 | -- | 0.2697 | -- | -1.14 | -- | -- | -- |
| BioSig Technologies Inc | 40.00k | -18.08m | 5.53m | 4.00 | -- | -- | -- | 138.37 | -1.97 | -1.97 | 0.0041 | 0.0066 | 0.0112 | -- | 1.07 | 10,000.00 | -489.14 | -269.73 | -4,711.71 | -363.11 | 65.00 | -- | -43,760.00 | -24,485.73 | -- | -3,115.67 | 0.00 | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
| Reflect Scientific Inc | 1.73m | -53.09k | 5.57m | 7.00 | -- | 2.83 | 72.30 | 3.21 | -0.0006 | -0.0006 | 0.0203 | 0.023 | 0.7197 | 0.8463 | 17.05 | 247,638.60 | -2.20 | 11.10 | -2.59 | 13.21 | 58.19 | 62.48 | -3.06 | 10.00 | 5.68 | -- | 0.00 | -- | -47.09 | -6.99 | -613.46 | -- | -- | -- |
| Venus Concept Inc | 69.81m | -49.93m | 6.00m | 304.00 | -- | 1.62 | -- | 0.0859 | -8.38 | -8.38 | 11.92 | 0.5103 | 0.751 | 1.03 | 2.25 | 229,634.90 | -53.53 | -32.71 | -82.19 | -44.01 | 68.39 | 68.16 | -71.28 | -48.50 | 1.30 | -2.75 | 0.9133 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Sharps Technology Inc | 0.00 | -8.21m | 6.75m | 3.00 | -- | 0.9353 | -- | -- | -0.4944 | -0.4944 | 0.00 | 0.2524 | 0.00 | -- | -- | -- | -75.56 | -- | -100.97 | -- | -- | -- | -- | -- | 0.6446 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Caduceus Software Systems Corp | 0.00 | -117.60k | 7.17m | 0.00 | -- | -- | -- | -- | -0.0004 | -0.0004 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -402.19 | -11,090.31 | -- | -- | -- | -- | -- | -- | -- | -76.88 | -- | -- | -- | -- | -20,519.89 | -- | -- | -- |
| Biotricity Inc | 12.24m | -18.28m | 7.19m | 55.00 | -- | -- | -- | 0.5868 | -1.74 | -1.74 | 1.18 | -1.27 | 2.12 | 1.67 | 8.08 | 222,624.00 | -248.61 | -269.25 | -- | -- | 71.89 | 58.93 | -117.41 | -258.94 | 0.106 | -0.6408 | -- | -- | 25.15 | 97.82 | 23.57 | -- | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 7.27m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Nexalin Technology Inc | 150.16k | -5.40m | 7.35m | 6.00 | -- | 3.90 | -- | 48.94 | -0.7261 | -0.7261 | 0.0202 | 0.1781 | 0.0446 | 0.1679 | 11.53 | 25,026.67 | -160.37 | -- | -202.23 | -- | 82.94 | -- | -3,598.50 | -- | 4.89 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| Agape ATP Corp | 1.38m | -2.45m | 7.39m | 21.00 | -- | 2.29 | -- | 5.36 | -0.6396 | -0.6396 | 0.3599 | 0.8366 | 0.4464 | 8.25 | 36.66 | 65,621.91 | -78.78 | -- | -111.56 | -- | 64.23 | -- | -176.47 | -- | 4.66 | -- | 0.0225 | -- | -22.92 | -- | -24.61 | -- | -- | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 7.94m | 6.00 | -- | -- | -- | 837.02 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
| Neurometrix Inc | 4.38m | -7.94m | 7.96m | 26.00 | -- | 0.4578 | -- | 1.82 | -5.50 | -5.50 | 2.91 | 8.58 | 0.2102 | 1.15 | 8.53 | 168,600.80 | -38.06 | -23.24 | -40.80 | -27.26 | 60.19 | 59.17 | -181.03 | -48.88 | 10.71 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 8.65m | 9.00 | -- | -- | -- | 5.37 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Guided Therapeutics Inc | 38.00k | -2.39m | 9.05m | 4.00 | -- | -- | -- | 238.11 | -0.0444 | -0.0444 | 0.0007 | -0.0829 | 0.0211 | 0.0365 | 8.44 | 9,500.00 | -120.81 | -136.13 | -- | -- | 42.11 | 29.39 | -5,721.05 | -3,666.67 | 0.0679 | -7.58 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Dror Ortho-Design Inc | 0.00 | -5.63m | 9.41m | 4.00 | -- | 5.68 | -- | -- | -0.012 | -0.012 | 0.00 | 0.0034 | 0.00 | -- | -- | -- | -577.48 | -140.50 | -1,394.24 | -- | -- | -- | -- | -118,188.00 | -- | -- | 0.00 | -- | -- | -- | -1,896.02 | -- | -- | -- |
| Precipio Inc | 16.72m | -3.83m | 9.90m | 51.00 | -- | 0.8103 | -- | 0.5921 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
Data as of Sep 20 2024. Currency figures normalised to NeuroMetrix Inc's reporting currency: US Dollar USD
2.74%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 15.12k | 0.75% |
| Geode Capital Management LLCas of 30 Jun 2024 | 13.70k | 0.68% |
| Citadel Securities LLCas of 30 Jun 2024 | 12.16k | 0.60% |
| Osaic Wealth, Inc. (Investment Management)as of 30 Jun 2024 | 6.58k | 0.33% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 5.01k | 0.25% |
| Tower Research Capital LLCas of 30 Jun 2024 | 1.71k | 0.08% |
| Accent Capital Management LLCas of 30 Jun 2024 | 625.00 | 0.03% |
| Tucker Asset Management LLCas of 30 Jun 2024 | 402.00 | 0.02% |
| Osaic Fa, Inc. (Investment Management)as of 30 Jun 2024 | 110.00 | 0.01% |
| Stephens Consulting LLCas of 30 Jun 2024 | 62.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
